Renal pathological changes after successful treatment of LCDD using cyclophosphamide, thalidomide, and dexamethasone

Dear Editor,Until now, there is no evidence-based consensus on the treatment for light chain deposition disease (LCDD). Some anti-myeloma agents, such as bortezomib-based, melphalan-based, or thali...